APA

Chavez Alvarez A. C., Zarifi Khosroshahi M., Côté M., Gagné-Boulet M. & Fortin S. (20190422). 4-(3-Alkyl-2-oxoimidazolidin-1-yl)-N-phenylbenzenesulfonamides as new antimitotic prodrugs activated by cytochrome P450 1A1 in breast cancer cells. : Bioorganic & medicinal chemistry.

Chicago

Chavez Alvarez Atziri Corin, Zarifi Khosroshahi Mitra, Côté Marie-France, Gagné-Boulet Mathieu and Fortin Sébastien. 20190422. 4-(3-Alkyl-2-oxoimidazolidin-1-yl)-N-phenylbenzenesulfonamides as new antimitotic prodrugs activated by cytochrome P450 1A1 in breast cancer cells. : Bioorganic & medicinal chemistry.

Harvard

Chavez Alvarez A. C., Zarifi Khosroshahi M., Côté M., Gagné-Boulet M. and Fortin S. (20190422). 4-(3-Alkyl-2-oxoimidazolidin-1-yl)-N-phenylbenzenesulfonamides as new antimitotic prodrugs activated by cytochrome P450 1A1 in breast cancer cells. : Bioorganic & medicinal chemistry.

MLA

Chavez Alvarez Atziri Corin, Zarifi Khosroshahi Mitra, Côté Marie-France, Gagné-Boulet Mathieu and Fortin Sébastien. 4-(3-Alkyl-2-oxoimidazolidin-1-yl)-N-phenylbenzenesulfonamides as new antimitotic prodrugs activated by cytochrome P450 1A1 in breast cancer cells. : Bioorganic & medicinal chemistry. 20190422.